Comments
ogromnyy-konchil t1_iqthosq wrote
Gabapentin is pretty fun if you don't have access to better drugs
100LittleButterflies t1_iqtoehf wrote
Idk the dose for this use but for nerve pain, I may as well have taken a sugar pill. No effect, good or bad, but doctors are so fond of it.
MyScrotesASaggin t1_iqus2z8 wrote
I had shingles on my face and it worked better than Percocet. Alcohol was the only other thing that helped with the pain.
100LittleButterflies t1_iqvljjt wrote
Ouch! I had it on my thigh (I went to Vegas and came back with a mysterious rash haha) and the pain was unique in a terrible way.
Slabby_the_Baconman t1_iqti51y wrote
Quite interesting. Thank you!
[deleted] t1_iqv655s wrote
[removed]
Chattypyre OP t1_iqth1o2 wrote
Interactive version
Looking for some feedback on this post and the website. There is a lot of good data on the site, but it's not all up to spec visually.
Data was parsed directly from clinicaltrials.gov.
100LittleButterflies t1_iqtoih8 wrote
Is diarrhea on twice or is there a difference between diarrhea and diarrheoa?
Chattypyre OP t1_iqtpaen wrote
It's there twice - they should ideally be on the same line.
Albus3957 t1_iqtjxjb wrote
No issue with your visualization skills. Nicely done. Two important suggestions however.
First, gabapentin would not be considered an insomnia medication. It's more of a seizure medication that's also used for certain types of pain.
Second and more importantly, it's not valid to take side effect data from separate studies performed on different groups of patients and combine them as you're doing here. You can only consider studies where the drugs were studied head to head in randomized, controlled trials.
An example in case this seems confusing. Zolpidem was developed for insomnia, so it's likely that in clinical trials the patients were selected because they suffered from insomnia. Gabapentin was developed to treat seizures and neuropathic pain, so trial patients were selected were selected for having those conditions. These are different types of patients, and headache occurs more commonly among the kinds of patients who got gabapentin. We would expect that in the gabapentin trial, more patients would report headaches compared with patients in the zolpidem trial - NOT because gabapentin necessarily causes more headaches, but just because that population suffers from headaches more commonly.
Hope this helps clarify. I hope you continue to work with healthcare data, because we all need valid analytics to help us make more informed health decisions. Good luck!